Filing Details
- Accession Number:
- 0001209191-22-056589
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-14 16:16:01
- Reporting Period:
- 2022-11-10
- Accepted Time:
- 2022-11-14 16:16:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
57725 | Lannett Co Inc | LCI | Pharmaceutical Preparations (2834) | 230787699 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1055404 | G Patrick Lepore | 1150 Northbrook Drive, Suite 155 Trevose PA 19053 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-11-10 | 100,000 | $0.49 | 587,145 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The price reported is a weighted average price. The shares were purchased in multiple transactions at prices ranging between $0.47 and $0.52. The reporting person undertakes to provide to Lannett Company, Inc., any security holder of Lannett Company, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.